![Sebastian Braun](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sebastian Braun
Algemeen Directeur bij Cheplapharm AG
Profiel
Sebastian Braun is currently the Co-Chief Executive Officer at Cheplapharm AG since 2003.
Prior to this, he worked as the Head of Logistics & Customer Service at RIEMSER Pharma GmbH from 2002 to 2003.
Mr. Braun obtained an MBA from the University of Gottingen.
Actieve functies van Sebastian Braun
Bedrijven | Functie | Begin |
---|---|---|
Cheplapharm AG
![]() Cheplapharm AG Medical DistributorsDistribution Services Cheplapharm AG engages in the management of companies that specialize in the production and sale of pharmaceutical products, food, personal care products, as well as medical devices. The company was founded by Kurt Teubner in 1998 and is headquartered in Greifswald, Germany. | Algemeen Directeur | 01-01-2003 |
Eerdere bekende functies van Sebastian Braun
Bedrijven | Functie | Einde |
---|---|---|
RIEMSER Pharma GmbH
![]() RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany. | Corporate Officer/Principal | 01-01-2003 |
Opleiding van Sebastian Braun
University of Gottingen | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
![]() | Distribution Services |
Bedrijven in privébezit | 1 |
---|---|
RIEMSER Pharma GmbH
![]() RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany. | Health Technology |